Nuclear Medicine Test Identifies Kidney Transplant Infection
By MedImaging International staff writers Posted on 28 Nov 2017 |
Image: An MRI showing focal restriction of diffusion (A), with corresponding upregulated CXCR4 expression (Photo courtesy of Hannover Medical School).
A novel positron emission tomography/magnetic resonance imaging (PET/MRI) test can determine whether a kidney transplant patient has developed infection in the transplanted tissue, according to a new study.
Researchers at Hannover Medical School (Germany) conducted a study involving 13 kidney transplant recipients with complicated urinary tract infections (UTIs) in order to determine whether molecularly targeted PET/MRI could enable the detection of leukocytes in renal allografts. The patients underwent both PET with a specific CXCR4 ligand (68Ga-pentixafor), and diffusion-weighted MRI. The spatial distribution and intensity of CXCR4 upregulation in the kidney transplants were analyzed and compared with urinalysis, clinical chemistry and bacteriology, and biopsy (if available).
The study showed that PET/MRI detected acute infection in the transplanted kidneys of nine patients, and lower UTI/non-urological infections in the remaining four patients. Leukocyte infiltration was identified by areas of CXCR4 upregulation versus unaffected parenchyma in PET, corresponding to areas with increased cell density under MRI. Transplant CXCR4 signal was mirrored by similar upregulation in lymphoid organs, and histopathology supported a correlation between CXCR4 signal and presence of leukocytes. The study was published in the November 2017 issue of The Journal of Nuclear Medicine.
“This work establishes CXCR4-targeted PET as a novel approach for imaging of infection, and it strengthens the role of nuclear medicine for renal imaging,” said lead author Thorsten Derlin, MD, of the department of nuclear medicine. “It demonstrates the potential of integrating state-of-the art imaging approaches - i.e., diffusion-weighted MRI and novel, highly specific PET tracers - for a comprehensive assessment of kidney disease, and has the potential to be translated into other settings of difficult-to-diagnose infections, such as cholangitis in transplanted patients and bone infections.”
CXCR-4 is an alpha-chemokine receptor specific for stromal-derived-factor-1 (SDF-1), a molecule with potent chemotactic activity for lymphocytes. After attachment to SDF-1, the CXCR4 protein activates signaling pathways inside the cell that help regulate cell growth and proliferation. CXCR4 is also involved in cell migration, especially that of hematopoietic stem cells in the bone marrow.
Related Links:
Hannover Medical School
Researchers at Hannover Medical School (Germany) conducted a study involving 13 kidney transplant recipients with complicated urinary tract infections (UTIs) in order to determine whether molecularly targeted PET/MRI could enable the detection of leukocytes in renal allografts. The patients underwent both PET with a specific CXCR4 ligand (68Ga-pentixafor), and diffusion-weighted MRI. The spatial distribution and intensity of CXCR4 upregulation in the kidney transplants were analyzed and compared with urinalysis, clinical chemistry and bacteriology, and biopsy (if available).
The study showed that PET/MRI detected acute infection in the transplanted kidneys of nine patients, and lower UTI/non-urological infections in the remaining four patients. Leukocyte infiltration was identified by areas of CXCR4 upregulation versus unaffected parenchyma in PET, corresponding to areas with increased cell density under MRI. Transplant CXCR4 signal was mirrored by similar upregulation in lymphoid organs, and histopathology supported a correlation between CXCR4 signal and presence of leukocytes. The study was published in the November 2017 issue of The Journal of Nuclear Medicine.
“This work establishes CXCR4-targeted PET as a novel approach for imaging of infection, and it strengthens the role of nuclear medicine for renal imaging,” said lead author Thorsten Derlin, MD, of the department of nuclear medicine. “It demonstrates the potential of integrating state-of-the art imaging approaches - i.e., diffusion-weighted MRI and novel, highly specific PET tracers - for a comprehensive assessment of kidney disease, and has the potential to be translated into other settings of difficult-to-diagnose infections, such as cholangitis in transplanted patients and bone infections.”
CXCR-4 is an alpha-chemokine receptor specific for stromal-derived-factor-1 (SDF-1), a molecule with potent chemotactic activity for lymphocytes. After attachment to SDF-1, the CXCR4 protein activates signaling pathways inside the cell that help regulate cell growth and proliferation. CXCR4 is also involved in cell migration, especially that of hematopoietic stem cells in the bone marrow.
Related Links:
Hannover Medical School
Latest Nuclear Medicine News
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure
- New PET Radiotracer Aids Early, Noninvasive Detection of Inflammatory Bowel Disease